JPRN-UMIN000007206招募中未知
Efficacy and cytokines of lenalidomide therapy in Japanese patients with relapsed or refractory multiple myeloma - Lenalidomide therapy in Japanese patients with relapsed or refractory multiple myeloma
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- ••Cardiac infarction within 6 months •Deep vein thrombosis or pulmonary embolism within 3 years •Tuberculosis, herpes simplex keratitis, mycosis, or other active infections at baseline •Uncontrollable diabetes mellitus, hypertension, peptic ulcer, or glaucoma •Posterior capsule opacification •Patients with mental illness •Those who are considered as inappropriate to register by attending physicians •Pregnant or breast feeding females •Known hypersensitivity to dexamethasone
研究者
相似试验
进行中（未招募）
不适用
Evaluation of efficacy and safety of Lenalidomide (Revlimid) in patients with POEMS Syndrome - ONC-2008-002POEMS SYNDROMEMedDRA version: 9.1Level: SOCClassification code 10029205EUCTR2008-003202-33-ITISTITUTO CLINICO HUMANITAS
已完成
不适用
Safety and efficacy of lenalidomide for patients with relapsed or refractory adult T cell leukemia/lymphoma post allogeneic hematopoietic stem cell transplantation, multi-institutional prospective observational trialAdult T-cell leukemia-lymphomaJPRN-UMIN000029635Kagoshima University33
终止
1 期
A Phase Ib study of lenalidomide in combination with imatinib for adult patients with chronic myeloid leukaemia in second molecular remissioACTRN12615001169538South Australian Health & Medical Research Institute (SAHMRI)3
进行中（未招募）
不适用
A Phase I/II Study of Lenalidomide in Patients with Chronic Myelomonocytic LeukemiaEUCTR2009-017147-33-ATAGMT gemeinnützige GmbH
进行中（未招募）
不适用
A prospective trial of treatment with Lenalidomide-Melphalan-Dexamethason (L-Mel-Dex) in untreated patients with AL amyloidosis (LEOMEX) - LEOMEXAL amyloidosisEUCTR2008-001405-41-DEGMIHO mbH